Our people

Having already headed up successful drug development companies, Chief Executive Officer Ian Garland and Chief Financial Officer David Mackney are the perfect team to help Vernalis realise its potential. They form part of a talented, highly qualified and knowledgeable senior management team that lead our commercial pipeline, manage our research programmes and oversee our NCE partner collaborations.

Our US Executive team is headed by Sandford Somner, who joined in May 2015 as President and Chief Operating Officer Vernalis Therapeutics, Inc., and by three Senior Vice Presidents covering Commercial, Pharmaceutical Quality Operations and Medical Affairs.

By leveraging our skills in research, our team secured multiple collaborations, including a new collaboration with Taisho during 2015, and we aim to continue to build on this success.